Literature DB >> 32373995

Bioinformatic analysis indicates that SARS-CoV-2 is unrelated to known artificial coronaviruses.

T Dallavilla1, M Bertelli, A Morresi, V Bushati, L Stuppia, T Beccari, P Chiurazzi, G Marceddu.   

Abstract

OBJECTIVE: SARS-CoV-2 is responsible for the present coronavirus pandemic and some suggestions were made about its possible artificial origin. We, therefore, compared SARS-CoV-2 with such known viruses that were prepared in the laboratory and other relevant natural strains to estimate their genetic relatedness.
MATERIALS AND METHODS: BLAST and clustalW were used to identify and align viral sequences of SARS-CoV-2 to other animal coronaviruses (human, bat, mouse, pangolin) and related artificial constructs. Phylogenetics trees were then prepared using iTOL.
RESULTS: Our study supports the notion that known artificial coronaviruses, including the chimeric SL-SHC014-MA15 synthesized in 2015, differ too much from SARS-CoV-2 to hypothesize an artificial origin of the latter. On the contrary, our data support the natural origin of the COVID-19 virus, likely derived from bats, possibly transferred to pangolins, before spreading to man.
CONCLUSIONS: Speculations about the artificial origin of SARS-CoV-2 are most likely unfounded. On the contrary, when carefully handled, engineered organisms provide a unique opportunity to study biological systems in a controlled fashion. Biotechnology is a powerful tool to advance medical research and should not be abandoned because of irrational fears.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32373995     DOI: 10.26355/eurrev_202004_21041

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

Review 1.  Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.

Authors:  Kaifu Gao; Rui Wang; Jiahui Chen; Limei Cheng; Jaclyn Frishcosy; Yuta Huzumi; Yuchi Qiu; Tom Schluckbier; Xiaoqi Wei; Guo-Wei Wei
Journal:  Chem Rev       Date:  2022-05-20       Impact factor: 72.087

Review 2.  Next-Generation Sequencing Reveals the Progression of COVID-19.

Authors:  Xiaomin Chen; Yutong Kang; Jing Luo; Kun Pang; Xin Xu; Jinyu Wu; Xiaokun Li; Shengwei Jin
Journal:  Front Cell Infect Microbiol       Date:  2021-03-11       Impact factor: 6.073

3.  The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey.

Authors:  Ilker Karacan; Tugba Kizilboga Akgun; N Bugra Agaoglu; Arzu Irvem; Gizem Alkurt; Jale Yildiz; Betsi Kose; A Serra Ozel; L Nilsun Altunal; Nisan Denizce Can; Yasemin Kendir Demirkol; Mehtap Aydin; Ozlem Akgun Dogan; Levent Doganay; Gizem Dinler Doganay
Journal:  North Clin Istanb       Date:  2020-05-15

Review 4.  SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs.

Authors:  Alessio Danilo Inchingolo; Angelo Michele Inchingolo; Ioana Roxana Bordea; Giuseppina Malcangi; Edit Xhajanka; Antonio Scarano; Felice Lorusso; Marco Farronato; Gianluca Martino Tartaglia; Ciro Gargiulo Isacco; Grazia Marinelli; Maria Teresa D'Oria; Denisa Hazballa; Luigi Santacroce; Andrea Ballini; Maria Contaldo; Francesco Inchingolo; Gianna Dipalma
Journal:  Microorganisms       Date:  2021-04-10

Review 5.  The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants.

Authors:  Alessio Danilo Inchingolo; Gianna Dipalma; Angelo Michele Inchingolo; Giuseppina Malcangi; Luigi Santacroce; Maria Teresa D'Oria; Ciro Gargiulo Isacco; Ioana Roxana Bordea; Sebastian Candrea; Antonio Scarano; Benedetta Morandi; Massimo Del Fabbro; Marco Farronato; Gianluca Martino Tartaglia; Mario Giosuè Balzanelli; Andrea Ballini; Ludovica Nucci; Felice Lorusso; Silvio Taschieri; Francesco Inchingolo
Journal:  Antioxidants (Basel)       Date:  2021-05-31

6.  COVID-19 vaccine candidates and vaccine development platforms available worldwide.

Authors:  Nilgun Duman; Zahraa ALzaidi; Busra Aynekin; Duygu Taskin; Busra Demirors; Abdulbaki Yildirim; Izem Olcay Sahin; Faik Bilgili; Eda Tahir Turanli; Tommaso Beccari; Matteo Bertelli; Munis Dundar
Journal:  J Pharm Anal       Date:  2021-09-14

7.  An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.

Authors:  Jeevan Malaiyan; Suresh Arumugam; Kamalraj Mohan; Gokul Gomathi Radhakrishnan
Journal:  J Med Virol       Date:  2020-07-14       Impact factor: 20.693

Review 8.  SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention.

Authors:  Alessio Danilo Inchingolo; Angelo Michele Inchingolo; Ioana Roxana Bordea; Giuseppina Malcangi; Edit Xhajanka; Antonio Scarano; Felice Lorusso; Marco Farronato; Gianluca Martino Tartaglia; Ciro Gargiulo Isacco; Grazia Marinelli; Maria Teresa D'Oria; Denisa Hazballa; Luigi Santacroce; Andrea Ballini; Maria Contaldo; Francesco Inchingolo; Gianna Dipalma
Journal:  Microorganisms       Date:  2021-03-04

9.  Identification of potential biomarkers and available drugs for oral squamous cell carcinoma.

Authors:  Zhijun Zhang; Fei Bi; Zhuang Zhang; Weidong Tian; Weihua Guo
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.